SVP & CFO of Nektar Therapeutics Inc (NKTR, Financial) Gil M Labrucherie (insider trades) sold 25,000 shares of NKTR on 07/10/2019 at an average price of $34.57 a share. The total sale was $864,250.
Nektar Therapeutics Inc is a biopharmaceutical company engaged in the development of new molecules to treat diseases with unmet medical needs. The company is researching and developing drugs for treating cancer, auto-immune disease and chronic pain. Nektar Therapeutics Inc has a market cap of $5.88 billion; its shares were traded at around $33.72 with a P/E ratio of 9.58 and P/S ratio of 5.19. GuruFocus has detected 2 severe warning signs with Nektar Therapeutics Inc. .
CFO Recent Trades:
- SVP & CFO Gil M Labrucherie sold 25,000 shares of NKTR stock on 07/10/2019 at the average price of $34.57. The price of the stock has decreased by 2.46% since.
- SVP & CFO Gil M Labrucherie sold 25,000 shares of NKTR stock on 06/17/2019 at the average price of $33.71. The price of the stock has increased by 0.03% since.
Directors and Officers Recent Trades:
- Director Lutz Lingnau sold 10,000 shares of NKTR stock on 07/08/2019 at the average price of $34.63. The price of the stock has decreased by 2.63% since.
For the complete insider trading history of NKTR, click here
.
